DETAILED ACTION
This action is in response to Applicant’s amendment filed 31 August 2026.
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 40 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Simonson (U.S. Publication No. 2005/0216002).
Simonson et al. discloses a cannula (42) for providing intraperitoneal access for a plurality of flexible robotic arms (see note*), the cannula comprising a distal end (40) which is insertable into a dilated aperture of a rectouterine pouch via transvaginal access (see note**); and an internal lumen (Figure 3) for passage therethrough plurality of flexible robotic arms to be passed therethrough (see note**); wherein an edge defining an aperture at the distal end of the cannula comprises a first edge portion extending along one side of the aperture and a second edge portion extending along an opposite side of the aperture, and the first edge portion is positioned more distally along the cannula than the second edge portion (Figure 4), and wherein a virtual cylinder circumscribing a lengthwise distal majority of the cannula has a substantially constant diameter along its length (Figure 3, 4, the cannulas being oblong in cross section and having constant long diameter has the claimed virtual cylinder)
*Note: Regarding the effect of the preamble, statements in the preamble reciting the purpose or
intended use of the claimed invention must be evaluated to determine whether or not the recited purpose or intended use results in a structural difference (or, in the case of process claims, manipulative difference) between the claimed invention and the prior art. Furthermore, a preamble generally is not limiting when the claim body describes a structurally complete invention such that deletion of the preamble phrase does not affect the structure or steps of the claimed invention (see MPEP 2111.02(II)).
**Note: With regard the statement of intended use and other functional statements, they do not impose any structural limitations on the claims which is capable of being used as claimed if one so desires to do so. In re Casey, 152 USPQ 235 (CCPA 1967) and In re Otto, 136 USPQ 458, 459 (CCPA 1963). Furthermore, the law of anticipation does not require that the reference “teach” what the subject patent teaches, but rather it is only necessary that the claims under attack “read on” something in the reference. Kalman v. Kimberly Clark Corp., 218 USPQ 781 (CCPA 1983). Furthermore, the manner in which a device is intended to be employed does not differentiate the claimed apparatus from prior art apparatus satisfying the claimed structural limitations. Ex parte Masham, 2 USPQ2d 1647 (1987). Therefore, recitation of the robotic arms are not given patentable weight. The amendments do not overcome intended use and other functional statements.
Regarding claim 42, the limitations only further limit functional language. As stated above, the robotic arms are not given patentable weight and the “operating mode” only further construes use. It is considered that the cannula of Simonson having all the structural limitations can be used in the manner described.
Regarding claim 43, an external cross section of the cannula is substantially constant along at least a lengthwise portion thereof comprising the distal end (Figure 3, 4)
Regarding claim 44, the cannula is rigid (being disclosed as a dilator/retractor {paragraph 30}, it can be construed that the cannula is rigid).
Regarding claim 45, Simonson et al. discloses a cannula (42) for providing intraperitoneal access for a plurality of flexible robotic arms (see note* above), the cannula comprising a distal end (40) which is insertable into a dilated aperture of a rectouterine pouch via transvaginal access (see note** above); and an internal lumen (Figure 3) for passage therethrough plurality of flexible robotic arms to be passed therethrough (see note**); wherein an edge defining an aperture at the distal end of the cannula comprises a first edge portion extending along one side of the aperture and a second edge portion extending along an opposite side of the aperture, and the first edge portion is positioned more distally along the cannula than the second edge portion (Figure 4), and wherein an external transverse cross section of the cannula is substantially constant along a lengthwise distal majority of the cannula (Figure 3, 4).
Regarding claim 46, the cannula is rigid (being disclosed as a dilator/retractor {paragraph 30}, it can be construed that the cannula is rigid).
Regarding claim 47. Simonson et al. discloses a cannula (42) for providing intraperitoneal access for a plurality of flexible robotic arms (see note*), the cannula comprising a distal end (40) which is insertable into a dilated aperture of a rectouterine pouch via transvaginal access (see note**); and an internal lumen (Figure 3) for passage therethrough plurality of flexible robotic arms to be passed therethrough (see note**); wherein an edge defining an aperture at the distal end of the cannula comprises a first edge portion extending along one side of the aperture and a second edge portion extending along an opposite side of the aperture, and the first edge portion is positioned more distally along the cannula than the second edge portion (Figure 4), and wherein a transverse cross-section of the internal lumen is substantially constant along a lengthwise distal majority of the cannula (Figure 3, 4).
Regarding claim 48, the cannula is rigid (being disclosed as a dilator/retractor {paragraph 30}, it can be construed that the cannula is rigid).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claim(s) 41 is/are rejected under 35 U.S.C. 103 as being unpatentable over Simonson (U.S. Publication No. 2005/0216002).
Regarding claim 41, a cross-section of an inner lumen of the cannula transverse to a longitudinal axis of the cannula has a long and a short axis (Figure 11, 14). Chen et al. fails to disclose long axis is at least twice as long as the short axis. It would have been obvious to one having ordinary skill in the art to construct the device of Chen et al. with the long axis at least twice as long as the short axis, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. In re Aller, 105 USPQ 233.
Response to Arguments
Applicant’s arguments with respect to claim(s) 40 and 41 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument.
Conclusion
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANDREW YANG whose telephone number is (571)272-3472. The examiner can normally be reached 9:00 - 9:00 M-F.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Truong can be reached at 571-272-4705. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ANDREW YANG/Primary Examiner, Art Unit 3775